Comments on the design of chemical libraries for screening

Molecular Diversity

Volumn 5, Issue 1, 2000, Pages 13-24

  Villar, Hugo O ^a   Koehler, Ryan T ^a  

^a Structural Biochemistry   (United States)

Author keywords

Conformational flexibility; Diversity analysis; Diversity measure; Library design; Molecular descriptors; Molecular representation; Pharmacophore representation; Small molecule libraries

Indexed keywords

ARTICLE; CHEMISTRY; CONFORMATIONAL TRANSITION; MATHEMATICAL ANALYSIS; MOLECULE; PRIORITY JOURNAL; THERMODYNAMICS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; LIGANDS; MODELS, CHEMICAL; MOLECULAR CONFORMATION; THERMODYNAMICS;

EID: 0034444471     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011326914800     Document Type: Article

References (30)

1. Gibbon, J.A., Taylor, E W. and Braeckman, R.A., In Gordon, E.M. and Kerwin, J.F. (Eds.), Combinatorial Chemistry and Molecular Diversity in Drug Discovery, Wiley-Liss, New York, NY, 1998, p. 453-474.
2. Martin, E.J. and Critchlow, R.E., Beyond mere diversity: Tayloring combinatorial libraries for drug discovery, J. Combinat. Chem., 1 (1999) 32-45.
3. Martin, Y.C., Brown, R.D. and Bure, M.G., Quantifying diversity. In Gordon, E.M. and Kerwin Jr., J.F. (Eds.), Combinatorial Chemistry and Molecular Diversity in Drug Discovery, Wiley-Liss, New York, NY, 1998, pp. 369-385.
4. Martin, Y.C., Challenges and prospects for computational aids to molecular diversity, Perspect. Drug Discov. Design, 7/8 (1997) 159-172.
5. Bures, M.G. and Martin, Y.C., Computational methods in molecular diversity and combinatorial chemistry, Curr. Opin. Chem. Biol., 2 (1998) 376-380.
6. Brown, R.D. and Martin, Y.C., The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding, J. Chem. Inf. Comput. Sci., 37 (1997) 1-9.
7. Brown, R.D., Descriptors for diversity analysis, Perspect. Drug Discov. Design, 7/8 (1997) 31-49.
8. Willett, P., Computational tools for the analysis of molecular diversity, Perspect. Drug Discov. Design, 7/8 (1997) 1-11.
9. Chapman, D., The measurement of molecular diversity: A three-dimensional approach, J. Comput.-Aided Mol. Design, 10 (1996) 501-512.
10. Lajiness, M.S., Dissimilarity-based compound selection techniques, Perspect. Drug Discov. Design, 7/8 (1997) 65-84.
11. Martin, E.J., Blaney, J.M., Siani, M.A., Spellmeyer, D.C., Wong, A.K. and Moos, W.H., Measuring diversity: experimental design of combinatorial libraries for drug discovery, J. Med. Chem., 38 (1995) 1431-1436.
12. Briem, H. and Kuntz I.D., Molecular similarity based on DOCK-generated fingerprints, J. Med. Chem., 39 (1996) 3401-3408.
13. Dixon, S.L. and Villar, H.O., Bioactive diversity and screening library selection via affinity fingerprinting, J. Chem. Inf. Comput. Sci., 38 (1998) 1192-1203.
14. Eaton, B.E., Gold, L. and Zichi, D.A., Let's get specific: The relationship between specificity and affinity, Chem. Biol., 2 (1995) 633-638.
15. Böhm, H.J. and Klebe, G., What can we learn from molecular recognition in protein-ligand complexesfor the design of new drugs?, Angew. Chem. Int. Ed. Engl., 35 (1996) 2588-2614.
16. Newton, C.G., Molecular diversity in drug design. Application to high speed synthesis and high throughput screening, In Dean, P.M. and Lewis, R.A. (Eds.), Molecular Diversity in Drug Design, Kluwer, Dordrecht, 1999, pp. 23-42.
17. Vajda, S., Weng, Z., Rosenfeld, R. and DeLisi, C., Effect of conformational flexibility and solvation on receptor-ligand binding free energies, Biochemistry, 33 (1994) 13977-13988.
18. Wang, J., Szewczuk, Z., Yue, S.Y., Tsuda, Y, Konishi, Y and Purissima, E.O., Calculation of relative binding free energies and configurational entropies: A structural and thermodynamic analysis of the nature of non-polar binding of thrombin inhibitors based on hirudin 55-65, J. Mol. Biol., 253 (1995) 473-493.
19. Vieth, M., Hirst, J.D. and Brooks III, C.L., Do active site conformations of small ligands correspond to low free-energy solution structures?, J. Comput. Aided Mol. Des., 12 (1998) 563-572.
20. Bostrom, J., Norrby, P.O., and Liljefors, T., Conformational energy penalties of protein bound ligands, J. Comput.-Aided Mol. Design, 12 (1998) 383-396.
21. Dixon, S.L. and Villar, H.O., Investigation of classification methods for the prediction of activity in diverse chemical libraries, J. Comput.-Aided Mol. Design, 13 (1999) 533-45.
22. MACCS-II Menu Reference, Version 2.2, MDL Information Systems, San Leandro, CA, 1994.
23. Johnson, M.A. and Maggiora, G.M., Concepts and Applications of Molecular Similarity, Wiley, New York, NY, 1990.
24. Lewis, R.A., Mason, J.S. and McLay, I., Similarity measures for rational set selection and analysis of combinatorial libraries: The Diverse Property Derived approach, J. Chem. Inf. Comput. Sci., 37 (1997) 599-614.
25. Mason, J.S., Morize, I., Menard, PR., Cheney, D.L., Hulme, C. and Labaudiniere, R.F., New 4-point pharmacophore method for molecular similarity and diversity applications, including a novel approach to the design of combinatorial libraries containing privileged substructures, J. Med. Chem., 42 (1999) 3251-3264.
26. Matter, H. and Potter, T., Comparing 3D pharmacophore triplets and 2D fingerprints for selecting diverse compound subsets, J. Chem. Inf. Comput. Sci., 39 (1999) 1211-1225.
27. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeny, P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Delivery Res., 23 (1997) 3-25.
28. Nogrady, T., Medicinal Chemistry: A Biochemical Approach, Oxford University Press, New York, NY, 1988.
29. Andrews, P.R., Craik, D.J. and Martin, J.L., Functional group contributions to drug receptor interactions, J. Med. Chem., 27 (1984) 1648-1657.
30. Kollman, P.A., Drug-target binding forces, In Wolff, M.E. (Ed.), Burger's Medicinal Chemistry and Drug Discovery, Vol. 1, Wiley, New York, NY, 1995, pp. 309-412.